National University Hospital, Singapore: Lung Neoplasms trials

The registry lists 12 Lung Neoplasms studies with National University Hospital, Singapore as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 2No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Liquid Biopsy-Based Pre-Screening to Streamline LDCT Lung Cancer Screening in High-Risk IndividualsRecruitingNCT07358715Not applicable
• Observational Study of Afatinib 30 mg DailyRecruitingNCT04909073
• Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell CarcinomaStatus unknownNCT03938012
• Diagnosis of Lung Cancer From Exhaled Breath With Silicon Biophotonic DeviceWithdrawnNCT01660087Not applicable
• Dysregulation of the C/EBPa Pathway in Human Lung Cancer and Search for New Biomarkers and/or Therapeutic TargetsStatus unknownNCT01619501
• A Retrospective Study of Biomarkers in Non-Small Cell Lung CancerStatus unknownNCT01100840
• A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung CancerStatus unknownNCT00958555
• Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung CancerStatus unknownNCT00938418Phase 2
• Hydroxychloroquine and Gefitinib to Treat Lung CancerStatus unknownNCT00809237Phase 1/2
• A Study of Serum Protein Profiling in Patients With Non-Small Cell Lung Cancer Treated With Gefitinib or ErlotinibCompletedNCT00717847
• Genetic Polymorphisms in UGT1A6 and UGT2B7 in Asian Population: Association With Lung Cancer PhenotypeStatus unknownNCT00717353
• Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility StudyCompletedNCT00717002